TSCAN THERAPEUTICS, INC. (TCRX)
Cellares and TScan Therapeutics Announce Agreement to Evaluate Automated Manufacturing of TSC-101 for Patients with Hematologic Malignancies
Cellares and TScan Therapeutics Announce Agreement to Evaluate Automated Manufacturing of TSC-101 for Patients with Hematologic Malignancies
Net Asset Value(s)
Trustee report to the holders of BONDS Series G, H from June 15, 2025 until the date of this report - Hermetic
Eason Technology Completes First $1Million Investments in Energy Fund and Facilitate Business Expansion Into The Energy Sector
Xiao-I Corporation Regains Full Compliance with Nasdaq Continued Listing Standards
Holding(s) in Company
Lemonade Brings Autonomous Car Insurance to Indiana
Btab Expands AI Powered Supplier Network to Connect Manufacturers with Its Global Reseller Ecosystem
OZOP Energy Solutions, Inc. Highlights Major Cultural Milestone as Unity Electro Fest Unveils 2026 Lineup Featuring Tiësto, Illenium, and Timmy Trumpet
WeRide Included in Hong Kong Stock Connect Program, Expanding Access to Mainland China Investors